HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Falini Selected Research

Nucleophosmin

2/2015Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.
9/2013A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.
10/2010Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia.
10/2009Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
7/2009Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.
7/2007Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas.
6/2006Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.
10/2005Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
8/2005Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia.
8/2000Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Falini Research Topics

Disease

13Neoplasms (Cancer)
02/2015 - 01/2000
10Lymphoma (Lymphomas)
06/2015 - 02/2000
7Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2015 - 01/2000
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2015 - 08/2005
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2009 - 11/2008
2Myeloid Sarcoma (Chloroma)
10/2009 - 07/2007
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2008 - 01/2002
2Lymphadenitis (Adenitis)
05/2006 - 09/2001
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2002 - 01/2002
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2002 - 02/2001
2Hodgkin Disease (Hodgkin's Disease)
01/2002 - 01/2001
2Multiple Myeloma
09/2001 - 07/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2013
1Lupus Nephritis
10/2013
1Hairy Cell Leukemia
12/2012
1Blast Crisis (Blast Phase)
07/2009
1Chromosome Aberrations (Chromosome Abnormalities)
02/2007
1Residual Neoplasm
06/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2002
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2002
1Lymphomatoid Papulosis
01/2002
1Sinus Histiocytosis (Rosai-Dorfman Disease)
09/2001
1Lymphadenopathy
09/2001
1Castleman Disease (Castleman's Disease)
09/2001
1Carcinogenesis
07/2001
1Melanoma (Melanoma, Malignant)
07/2001
1Sclerosis
02/2001
1Acute Promyelocytic Leukemia
11/2000
1Leukemia
11/2000
1Common Variable Immunodeficiency
09/2000
1Rheumatoid Arthritis
04/2000

Drug/Important Bio-Agent (IBA)

12NucleophosminIBA
02/2015 - 01/2000
9Proteins (Proteins, Gene)FDA Link
10/2005 - 02/2000
7Anaplastic Lymphoma KinaseIBA
06/2015 - 01/2000
4ParaffinIBA
10/2009 - 11/2000
2Biological ProductsIBA
02/2015 - 07/2002
2AntibodiesIBA
07/2002 - 09/2001
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2002 - 08/2000
2Tyrosine (L-Tyrosine)FDA Link
01/2002 - 09/2000
2Monoclonal AntibodiesIBA
11/2000 - 06/2000
1Proteasome InhibitorsIBA
06/2015
1Interleukin-17 (Interleukin 17)IBA
10/2013
1MicroRNAs (MicroRNA)IBA
12/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2008
1SuperantigensIBA
05/2006
1Bleomycin (Blenoxane)FDA LinkGeneric
09/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2002
1Prednisone (Sone)FDA LinkGeneric
09/2002
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2002
1Mitoxantrone (Novantrone)FDA LinkGeneric
09/2002
1Etoposide (VP 16)FDA LinkGeneric
09/2002
1Vincristine (Oncovin)FDA LinkGeneric
09/2002
1Muramidase (Lysozyme)IBA
07/2002
1S100 Proteins (S 100 Protein)IBA
07/2002
1AntigensIBA
07/2002
1PhosphotyrosineIBA
01/2002
1EpitopesIBA
09/2001
1Peroxidase (Myeloperoxidase)IBA
09/2001
1Immunoglobulins (Immunoglobulin)IBA
01/2001
1Transcription Factors (Transcription Factor)IBA
01/2001
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
11/2000
1promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
11/2000
1Pyridinolcarbamate (P23)IBA
06/2000
1Cyclin AIBA
06/2000
1PhosphoproteinsIBA
02/2000
1Indicators and Reagents (Reagents)IBA
01/2000
1Phosphotransferases (Kinase)IBA
01/2000

Therapy/Procedure

6Therapeutics
11/2008 - 04/2000
4Drug Therapy (Chemotherapy)
12/2002 - 02/2001
1Orchiectomy (Orchidectomy)
09/2002
1Immunotherapy
09/2001
1Radiotherapy
02/2001